Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Darbepoetin alfa modulation of oxidative stress and microinflammation genes in renal transplant recipients
2010-020401-32Phase 4Active
- Sponsor
- Policlinico di Bari
- Start
- Sep 2010
- Modality
- Erythropoietins → Hormones & Growth Factors → Recombinant Proteins and Enzymes, Interleukins → Cytokines & Interferons → Recombinant Proteins and Enzymes, Colony Stimulating Factors → Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of darbepoetin alfa in chronic kidney disease (CKD) and anemia of renal disease (2 arms), sponsored by Policlinico di Bari. Started Sep 2010; status: active.
02
Drugs
darbepoetin alfa
03
Conditions
chronic kidney disease (CKD)anemia of renal disease
Beyond the preview
Go deeper on 2010-020401-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020401-32.